Chargement en cours...
Cholesterol-lowering drugs: science and marketing
Long-term use of statin therapy is essential to obtain clinical benefits, but adherence is often suboptimal and some patients are also reported to fail because of ‘statin resistance'. The identification of PCSK9 as a key factor in the LDL clearance pathway has led to the development of new mono...
Enregistré dans:
| Publié dans: | J R Soc Med |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5305008/ https://ncbi.nlm.nih.gov/pubmed/28084157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0141076816681951 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|